EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition

Sung Min Son, Farah H Siddiqi, Ana Lopez, Rizwan Ansari, Sylwia D Tyrkalska, So Jung Park, Tilo Kunath, Emmanouil Metzakopian, Angeleen Fleming, David C Rubinsztein

Neuron · 2025-06 · 113 (12) · 1908-1924.e13

DOI: 10.1016/j.neuron.2025.03.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2025-06. Verfasst von Sung Min Son und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK; UK Dementia Research Institute, Cambridge Institute for Medi…. Hauptthemen laut MEDLINE: alpha-Synuclein, Autophagy, Parkinson Disease, E1A-Associated p300 Protein. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, UK Dementia Research Institute, UK Research and Innovation Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triplications and certain point mutations in the SNCA gene, encoding alpha-synuclein (α-Syn), cause Parkinson's disease (PD). Here, we demonstrate that the PD-causing A53T α-Syn mutation and elevated α-Syn expression perturb acetyl-coenzyme A (CoA) and p300 biology in human neurons and in the CNS of zebrafish and mice. This dysregulation is mediated by activation of ATP-citrate lyase (ACLY), a key enzyme that generates acetyl-CoA in the cytoplasm, via two mechanisms. First, ACLY activity increases acetyl-CoA levels, which activate p300. Second, ACLY activation increases LKB1 acetylation, which inhibits AMPK, leading to increased cytoplasmic and decreased nuclear p300. This lowers histone acetylation and increases acetylation of cytoplasmic p300 substrates, like raptor, which causes mechanistic target of rapamycin complex 1 (mTORC1) hyperactivation, thereby impairing autophagy. ACLY inhibitors rescue pathological phenotypes in PD neurons, organoids, zebrafish, and mouse models, suggesting that this pathway is a core feature of α-Syn toxicity and that ACLY may be a suitable therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinAutophagyParkinson DiseaseE1A-Associated p300 ProteinAnimalsHumansZebrafishMiceNeuronsCytoplasmMutationMechanistic Target of Rapamycin Complex 1

Stichwörter der Autor:innen

ACLYAMPKParkinson's diseaseacetyl-CoAacetylationalpha-synucleinautophagymTORC1nucleocytoplasmic shuttling of p300

Substanzen

alpha-SynucleinE1A-Associated p300 ProteinMechanistic Target of Rapamycin Complex 1SNCA protein, human

Autor:innen und Institutionen

  • Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK; UK Dementia Research Institute, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.
  • Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK; UK Dementia Research Institute, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK; Departmen…
  • UK Dementia Research Institute, Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
  • Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
  • UK Dementia Research Institute, Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK; bit.bio, The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, UK.
  • Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK; UK Dementia Research Institute, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK. Electroni…

Förderung

  • Horizon 2020
  • UK Dementia Research Institute
  • UK Research and Innovation Medical Research Council
  • Recycled Materials Resource Center
  • NIHR Cambridge Biomedical Research Centre
  • National Institute on Handicapped Research
  • John Black Charitable Foundation
  • Horizon 2020 Framework Programme

Zitieren

APA

Son, S. M., Siddiqi, F. H., Lopez, A., Ansari, R., Tyrkalska, S. D., Park, S. J., Kunath, T., Metzakopian, E., Fleming, A., & Rubinsztein, D. C. (2025). Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition. Neuron, 113(12), 1908-1924.e13. https://doi.org/10.1016/j.neuron.2025.03.028

Vancouver

Son SM, Siddiqi FH, Lopez A, Ansari R, Tyrkalska SD, Park SJ, et al. Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition. Neuron. 2025;113(12):1908-1924.e13. doi:10.1016/j.neuron.2025.03.028

BibTeX
@article{Son2025,
  author = {Son, Sung Min and Siddiqi, Farah H and Lopez, Ana and Ansari, Rizwan and Tyrkalska, Sylwia D and Park, So Jung and Kunath, Tilo and Metzakopian, Emmanouil and Fleming, Angeleen and Rubinsztein, David C},
  title = {Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition},
  journal = {Neuron},
  year = {2025},
  volume = {113},
  number = {12},
  pages = {1908--1924.e13},
  doi = {10.1016/j.neuron.2025.03.028}
}
Kostenlos starten →